GMO Benchmark-Free Allocation packages the firm’s contrarian views and value-driven asset-class forecasts. The differentiated approach is consistently applied by a research-focused team, but it can face prolonged periods of underperformance.
GMO Benchmark-Free Allocation IV GBMBX Fund Analysis
Morningstar’s Analysis GBMBX
Will GBMBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar